- Trials with a EudraCT protocol (427)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6)
427 result(s) found for: Pelvis.
Displaying page 1 of 22.
EudraCT Number: 2014-000669-39 | Sponsor Protocol Number: URU04 | Start Date*: 2014-06-13 | |||||||||||
Sponsor Name:Gregers Gautier Hermann | |||||||||||||
Full Title: Endoscopic treatment of neoplasia in the upper urinary tract and the value of fluorescence guided endoscopic follow up. | |||||||||||||
Medical condition: Urothelial tumors in the renal pelvis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004857-33 | Sponsor Protocol Number: 0416-ASG | Start Date*: 2017-06-01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:AIO-Studien-gGmbH | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A phase II single arm clinical trial of a Tailored ImmunoTherapy Approach with Nivolumab in subjects with metastatic or advanced Transitional Cell Carcinoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: subjects in untreated (1st line)* and platinum-based pretreated (2nd and 3rd line) subjects with metastatic or surgically unresectable TCC *First-line has been finally stopped since 06.01.2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005403-17 | Sponsor Protocol Number: KH-MS-JAW-01 | Start Date*: 2007-12-10 | ||||||||||||||||
Sponsor Name:GE Healthcare | ||||||||||||||||||
Full Title: A prospective, comparative single center study of Hexvix® fluorescence uretero-renoscopy and white light uretero-renoscopy in the detection of upper urinary tract urothelial cell carcinoma | ||||||||||||||||||
Medical condition: Upper urinary tract (ureters and pyela/renal pelvises) urothelial cell carcinoma for which blue light uretero-renoscopy and biopsies are performed for diagnosis. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007412-15 | Sponsor Protocol Number: CSET 2008/1443 | Start Date*: 2009-01-26 | |||||||||||
Sponsor Name:Institut Gustave Roussy | |||||||||||||
Full Title: Essai de phase III comparant la perfusion isolée pelvienne (PIP) avec du TNF-α 0,3 mg et du melphalan 1,5 mg/kg versus traitement standard dans les tumeurs pelviennes localement évoluées d’origine ... | |||||||||||||
Medical condition: Tumeur pelvienne localement évoluée d’origine gynécologique ou digestive | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002577-33 | Sponsor Protocol Number: ICR-CTSU/2011/10031 | Start Date*: 2012-01-04 | |||||||||||
Sponsor Name:Institute of Cancer Research | |||||||||||||
Full Title: A Phase III randomised trial of Peri-Operative chemotherapy versus sUrveillance in upper Tract urothelial cancer | |||||||||||||
Medical condition: Upper urinary tract transitional cell carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003498-27 | Sponsor Protocol Number: JEVTCC-SOGUG-2011-04 | Start Date*: 2011-12-19 | |||||||||||
Sponsor Name:Grupo Español de Tratamiento de Tumores Genitourinarios (SOGUG)-Spanish Genitourinary Oncologic Group | |||||||||||||
Full Title: A phase II open label study of cabazitaxel in patients with advanced or metastatic transitional cell carcinoma of the urothelium who have progressed ?12 months after a previous platinum based chemo... | |||||||||||||
Medical condition: advanced or metastatic transitional cell carcinoma of the urothelium | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001841-34 | Sponsor Protocol Number: PLUTO2011 | Start Date*: 2012-01-12 | |||||||||||||||||||||
Sponsor Name:NHS Greater Glasgow Health Board [...] | |||||||||||||||||||||||
Full Title: A Randomised Phase II study investigating pazopanib vs weekly paclitaxel in relapsed or progressive Transitional Cell Carcinoma (TCC) of the urothelium. | |||||||||||||||||||||||
Medical condition: Relapsed or progressive Transitional Cell Carcinoma (TCC) of the urothelium | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-005983-12 | Sponsor Protocol Number: INT01/12 | Start Date*: 2012-03-21 | ||||||||||||||||||||||||||
Sponsor Name:ISTITUTO NAZIONALE PER LA CURA TUMORI | ||||||||||||||||||||||||||||
Full Title: Phase II study of the fully human monoclonal antibody against transforming growth factor-beta (TGF-beta) receptor ALK1 (PF-03446962) in relapsed or refractory urothelial cancer (UC) failing first-l... | ||||||||||||||||||||||||||||
Medical condition: Relapsed or refractory urothelial cancer after failure of 1st line platinum-containing chemotherapy regimen for metastatic disease. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-007591-42 | Sponsor Protocol Number: SPON416-07(WCTU011) | Start Date*: 2009-01-14 | |||||||||||||||||||||
Sponsor Name:Cardiff University | |||||||||||||||||||||||
Full Title: A Phase II single-arm trial to evaluate cisplatin and gemcitabine chemotherapy in combination with sunitinib for first-line treatment of patients with advancd transitional carcinoma of the urothelium. | |||||||||||||||||||||||
Medical condition: Advanced transitional cell carcinoma of the urothelium. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-004628-39 | Sponsor Protocol Number: ABACUS-2 | Start Date*: 2020-12-16 | ||||||||||||||||
Sponsor Name:Queen Mary University of London | ||||||||||||||||||
Full Title: A phase II study of neoadjuvant immune checkpoint inhibitors in urothelial cancer | ||||||||||||||||||
Medical condition: Tumours of the urothelial tract requiring surgery (T1 high grade-T4a of the bladder, rare histological subtypes) and upper urinary tract (high grade or high risk) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004222-24 | Sponsor Protocol Number: GUF 001 | Start Date*: 2008-03-10 | |||||||||||
Sponsor Name:Dekan des FB Medizin der Johann-Wolfgang Goethe-Universität | |||||||||||||
Full Title: Intra-individual, randomized comparison of the MRI contrast agents Gadovist 1.0 versus Dotarem when imaging the pelvis in patients with spondylarthritides, evaluated in a blinded read | |||||||||||||
Medical condition: Polyarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000403-32 | Sponsor Protocol Number: LIDrfvm001 | Start Date*: 2019-07-23 |
Sponsor Name:Roessingh Research and Development | ||
Full Title: The effect of lidocaïne injections in the m. vastus intermedius and the m. rectus femoris on the gait pattern in patients walking with stiff knee gait after a stroke. | ||
Medical condition: Patients walking with stiff knee gait after a stroke | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-007615-82 | Sponsor Protocol Number: SPON417-07 | Start Date*: 2009-09-16 | |||||||||||||||||||||
Sponsor Name:Cardiff University | |||||||||||||||||||||||
Full Title: A Phase I/II single-arm trial to evaluate the combination of cisplatin and gemcitabine with the mTOR inhibitor temsirolimus for treatment of advanced cancers, including first-line treatment of pati... | |||||||||||||||||||||||
Medical condition: Advanced cancers including transitional cell carcinoma of the urothelium | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-005241-36 | Sponsor Protocol Number: | Start Date*: 2005-06-21 |
Sponsor Name:ACROSS Group | ||
Full Title: Phase II clinical trial of Cisplatin, Gemcitabine and Trastuzumab (Herceptin®) as first line treatment of advanced irresectable transitional-cell urothelial carcinoma with overexpression of C-erbB-2 | ||
Medical condition: Advanced irresectable transitional-cell urothelial carcinoma, that includes cancer of the bladder, ureter and renal pelvis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-003962-24 | Sponsor Protocol Number: VEN1 | Start Date*: 2008-10-15 | |||||||||||
Sponsor Name:Fredericia hospital | |||||||||||||
Full Title: visceral pain originating from the upper urinary tract - a randomised controlled trial on the effect of morphine and oxycodone in patients undergoing percutaneus nephrolithotomy (PCNL) | |||||||||||||
Medical condition: kidney stone | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-003906-81 | Sponsor Protocol Number: A7-2 | Start Date*: 2005-01-14 |
Sponsor Name:Oncology Institute of Vilnius University | ||
Full Title: Chemoradiation with once weekly gemcitabine for invasive bladder cancer | ||
Medical condition: Invasive transitional cell bladder cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004494-41 | Sponsor Protocol Number: CLIN2001UCM301 | Start Date*: 2021-11-11 | ||||||||||||||||
Sponsor Name:Steba biotech S.A. | ||||||||||||||||||
Full Title: Multicenter Phase 3 Pivotal Study to Evaluate the Safety and Efficacy of TOOKAD (padeliporfin) Vascular Targeted Photodynamic Therapy in the Treatment of Low-Grade Upper Tract Urothelial Cancer | ||||||||||||||||||
Medical condition: Low Grade Upper Tract Urothelial Cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) IT (Ongoing) AT (Ongoing) ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000050-32 | Sponsor Protocol Number: GE012-097 | Start Date*: Information not available in EudraCT | |||||||||||||||||||||
Sponsor Name:GE Healthcare Ltd. and its affiliates | |||||||||||||||||||||||
Full Title: A phase 4 randomized, double-blind study comparing patient comfort and safety between iodixanol 320 mg I/ml and iopamidol 370 mg I/ml in patients undergoing contrast-enhanced computed tomographic (... | |||||||||||||||||||||||
Medical condition: Patients undergoing CECT imaging of the abdomen/pelvis as part of their routine medical care. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-001199-23 | Sponsor Protocol Number: ICR-CTSU/2014/10048 | Start Date*: 2016-10-11 | |||||||||||
Sponsor Name:The Institute of Cancer Research | |||||||||||||
Full Title: InPACT - International Penile Advanced Cancer Trial (International Rare Cancer Initiative) | |||||||||||||
Medical condition: Locally advanced squamous carcinoma of the penis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001815-19 | Sponsor Protocol Number: Ga-68-PSMA-11 | Start Date*: 2017-08-04 | |||||||||||
Sponsor Name:Deutsches Krebsforschungszentrum (DKFZ), Stiftung des öffentlichen Rechts | |||||||||||||
Full Title: An open-label, single-arm, rater-blinded, multicenter phase 1/2 study to assess safety and diagnostic accuracy and radiotherapeutic implications of pre-operative Ga-68-PSMA-11 PET/CT imaging in com... | |||||||||||||
Medical condition: Prostate cancer (PCA) with high risk of metastasis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.